SARS-CoV-2 variant biology: immune escape, transmission and fitness
, … Genomics UK Consortium de Silva Thushan I … - Nature Reviews …, 2023 - nature.com
In late 2020, after circulating for almost a year in the human population, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) exhibited a major step change in its adaptation …
syndrome coronavirus 2 (SARS-CoV-2) exhibited a major step change in its adaptation …
HIV-2: the forgotten AIDS virus
TI de Silva, M Cotten, SL Rowland-Jones - Trends in microbiology, 2008 - cell.com
HIV type 2 (HIV-2), a closely related retrovirus discovered a few years after HIV type 1,
causes AIDS in only a minority of infected individuals. Determining why HIV-2 causes …
causes AIDS in only a minority of infected individuals. Determining why HIV-2 causes …
[PDF][PDF] Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus
…, DG Partridge, CM Evans, TM Freeman, TI de Silva… - Cell, 2020 - cell.com
A SARS-CoV-2 variant carrying the Spike protein amino acid change D614G has become
the most prevalent form in the global pandemic. Dynamic tracking of variant frequencies …
the most prevalent form in the global pandemic. Dynamic tracking of variant frequencies …
[HTML][HTML] Immune reconstitution following autologous hematopoietic stem cell transplantation for multiple sclerosis: a review on behalf of the EBMT autoimmune …
MT Cencioni, A Genchi, G Brittain, TI de Silva… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS) is a central nervous system (CNS) disorder, which is mediated by an
abnormal immune response coordinated by T and B cells resulting in areas of inflammation, …
abnormal immune response coordinated by T and B cells resulting in areas of inflammation, …
[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
…, J Sillitoe, TI de Silva, D Wang, D Kwiatkowski… - Cell reports, 2021 - cell.com
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…
complications. These complications are likely to have important short-term and long-…
[HTML][HTML] T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre …
Background Previous infection with SARS-CoV-2 affects the immune response to the first
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
…, K Chechi, GS Cooke, A da Silva Filipe, T de Silva… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …
limited insights into mucosal defences that prevent viral replication and onward transmission. …
